Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with neutropenia

https://doi.org/10.1016/0090-1229(92)90039-QGet rights and content

Abstract

The results of an open-label, randomized, Phase III trial of r-methionyl human granulocyte-colony-stimulating factor (r-metHuG-CSF) in 41 patients with severe chronic neutropenia (SCN) are reported. Patients with diagnoses of congenital, cyclic, and idiopathic neutropenia, with histories of recurrent infections, were evaluated. The primary objective of the trial was to evaluate the ability of r-metHuG-CSF to increase the ANC to > 1500/mm3. A secondary objective was to evaluate variables associated with infection-related morbidity in SCN. r-metHuG-CSF treatment consisted of 1 month of dose titration followed by 4 months of treatment at an optimal dose. Patients were randomized to either immediate treatment with r-metHuG-CSF (Group A) or four months of observation followed by r-metHuG-CSF treatment (Group B). r-metHuG-CSF was administered by daily, subcutaneous injection with initial doses of 3 to 10 μg/kg/day. Forty of 41 patients who received r-metHuG-CSF had a complete response (median ANC > 1500/mm3 during 4 months of r-metHuG-CSF treatment). All cases of gingivitis and severe mouth ulcers resolved upon treatment with r-metHuG-CSF. Serious infections were also eliminated. Only one patient failed to show clinical improvement in response to r-metHuG-CSF treatment. Adverse reactions during the first 5 months of treatment were mild. Splenomegaly (mild) was noted in some patients. The administration of r-metHuG-CSF in patients with SCN significantly increased the ANC (P < 0.001) and was accompanied by a marked reduction in infectious complications.

References (42)

  • J.B. Bussel et al.

    Autoimmune neutropenia of childhood

    Cirt. Rev. Oncol. Hematol.

    (1987)
  • U. Mintz et al.

    Norman granulocyte colony-forming cells in the bone marrow of Yemenite Jews with genetic neutropenia

    Blood

    (1973)
  • K. Welte et al.

    Differential effects of granulocyte macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia

    Blood

    (1990)
  • S. Vadhan-Raj et al.

    Stimulation of myelopoiesis in a patient with congenital neutropenia: Biology and nature of response to recombinant human granulocyte-macrophage colony-stimulating factor

    Blood

    (1990)
  • D.W. Golde

    Overview of myeloid growth factors

    Semin. Hematol.

    (1990)
  • J.E. Groopman et al.

    Hematopoietic growth factors: Biology and clinical applications

    N. Engl. J. Med.

    (1989)
  • K. Vallenga et al.

    Independent regulation of M-CSF and G-CSF gene expression in human monocytes

    Blood

    (1988)
  • W.K. Seelentag et al.

    Additional effects of interleukin 1 and tumor necrosis factor—On the accumulation of three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells

    EMBO J.

    (1987)
  • C. Cheers et al.

    Production of colony-stimulating factors (CSFs) during infection: Separate determinations of macrophage-granulocyte-macrophage- and multi-CSFs

    Infect. Immun.

    (1988)
  • A. Bartocci et al.

    Macrophages specifically regulate the concentration of their own growth factor in the circulation

  • C.A. Sieff

    Biology and clinical aspects of the hematopoietic growth factors

    Annu. Rev. Med.

    (1990)
  • Cited by (0)

    Presented as part of a symposium entitled “Future Directions of Cytokine and Immunoglobulin Therapy,” January 11–12, 1991, Tucson, AZ.

    View full text